Get the insights you need to successfully launch an oncology product
Saving lives by enhancing access
One manufacturer, whose product demonstrated effectiveness under real-world conditions, faced a critical problem: all their clinical evidence was scattered across thousands of patient records, and those records are extremely difficult to access and analyze. The client turned to Xcenda for a range of possible options for acquiring, analyzing, and presenting the product’s real-world clinical efficacy data to stakeholders. In very short order, this manufacturer had credible real-world evidence of its oncology product’s impact on patient outcomes. This evidence was broad-based, having been derived from a data set that included hundreds of thousands of patients.
Meet The Expert
Kasia Shields, PharmD, MBA, BCOP, BCPS
Dr. Shields is Director of Medical Communications at Xcenda, leading and conducting numerous oncology-related HEOR engagements. Her primary responsibilities include content development and review of global value dossiers, formulary kits, advisory boards, and scientific publications. She also provides strategic oncology insights and assists in development and review of value propositions, compendia analyses, and budget impact models. Dr. Shields' experience ranges across various cancer areas including hematology, oncology, stem cell transplant, supportive care, and non-malignant hematology.
Start a conversation
We’re value drivers and problem solvers. Let us connect you with experts who understand your world and what success demands.